NCT02810327View on ClinicalTrials.gov

Alpha-1 Carrier Genomics Study

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Alpha-1 Antitrypsin DeficiencyEmphysemaCOPDSmoking
Interventions
GENETIC

Genetic Sequencing

Sequencing of the SERPINA1 gene

Trial Locations (1)

29425

Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine, Charleston

Sponsors

Collaborators (1)

CSL Behring
All Listed Sponsors
collaborator

CSL Behring

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT02810327 - Alpha-1 Carrier Genomics Study | Biotech Hunter | Biotech Hunter